Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Claudio Jommi1

  • 1Dipartimento di Scienze del Farmaco, Università del Piemonte Orientale, Novara - Italy.

Global & Regional Health Technology Assessment
|October 1, 2025
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and Consistency.

Journal of market access & health policy·2026
Same author

Global & regional health technology assessment·2026
Same author

Global & regional health technology assessment·2026
Same author

Paving the road for a successful EU HTA Reform implementation.

Global & regional health technology assessment·2025
Same author

Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?

Journal of market access & health policy·2025
Same author

The Costs of Digital Health Interventions to Improve Immunization Data in Low- and Middle-Income Countries: Multicountry Mixed Methods Study.

Journal of medical Internet research·2025
Same journal

Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.

Global & regional health technology assessment·2026
Same journal

Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.

Global & regional health technology assessment·2026
Same journal

Comments on: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.

Global & regional health technology assessment·2026
Same journal

Author's reply to comments to: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.

Global & regional health technology assessment·2026
Same journal

Procedural activity and dynamics of the new Italian Scientific and Economic Committee (CSE): a one-year observational analysis.

Global & regional health technology assessment·2026
Same journal

Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma.

Global & regional health technology assessment·2026
See all related articles